Combination therapies for treating cancer
US12156872B2 · kind B2 · utility
0Cited by
11References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 9, 2018 |
| Grant date | Dec 3, 2024 |
| Priority date | — |
| Expiry date | May 10, 2040 |
Classification
- Technology area (CPC H)Electricity
- CPC primaryH01R13/516
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of treatment for recurrent cancer(s) through combination therapy with an agent that inhibits programmed death-1 protein (PD-1) signaling and an agent that inhibits poly [ADP-ribose] polymerase (PARP) signaling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.